Egan-Jones Urges XFLT Shareholders to Reject Sub-Adviser Change, Highlighting Outperformance and Fee Shifts
XFLT sits 18% above its 52-week low of $14.925.
Summary
Egan-Jones, an independent proxy advisory firm, recommends XFLT shareholders vote against replacing sub-adviser Octagon, citing misleading performance comparisons and a fee shift that benefits the primary adviser XAI without shareholder gain.
Key Events · Corporate Governance and Compliance · XFLT
-
Egan-Jones Recommends Against Sub-Adviser Change
Independent proxy advisory firm Egan-Jones recommends XFLT shareholders vote AGAINST the proposal to replace Octagon with King Street as sub-adviser at the July 30 special meeting.
-
Performance Benchmark Dispute Validated
Egan-Jones agrees with Octagon that the Board's performance comparison to an unlevered loan index is inappropriate; its own weighted analysis shows Octagon outperforming a fair composite in three of the last five years.
-
Fee Restructuring Benefits XAI, Not Shareholders
Egan-Jones calculates that under the proposed King Street arrangement, XAI's share of the fixed fee pool would increase from approximately 41% to 48%, a roughly 17% relative increase, with no direct benefit to shareholders.
-
Board Independence Questioned
Egan-Jones notes that two of the six trustees who approved the transaction have a current or former direct financial relationship with XAI, the party that stands to benefit from the fee restructuring.
Analysis · XFLT · Unknown
Independent proxy advisor Egan-Jones has recommended voting against the proposal to replace Octagon as sub-adviser, directly challenging the Board's performance narrative and exposing a fee restructuring that benefits XAI at shareholders' expense. This third-party validation significantly strengthens Octagon's hand in the ongoing proxy fight, increasing the likelihood that the July 30 special meeting vote could go against the Board.
At the time of this filing, XFLT was trading at $17.64 on NYSE in the Unknown sector, with a market capitalization of approximately $269.7M. The 52-week trading range was $14.93 to $28.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.